Novo Nordisk A/S (NVO)
129.21
+0.90
(+0.70%)
USD |
NYSE |
May 01, 16:00
125.59
-3.62
(-2.80%)
Pre-Market: 06:06
Novo Nordisk EPS Diluted (Quarterly): 0.7086 for Dec. 31, 2023
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.7086 |
| September 30, 2023 | 0.7302 |
| June 30, 2023 | 0.6307 |
| March 31, 2023 | 0.6331 |
| December 31, 2022 | 0.4138 |
| September 30, 2022 | 0.4292 |
| June 30, 2022 | 0.4195 |
| March 31, 2022 | 0.4691 |
| December 31, 2021 | 0.3661 |
| September 30, 2021 | 0.4178 |
| June 30, 2021 | 0.4262 |
| March 31, 2021 | 0.4417 |
| December 31, 2020 | 0.3212 |
| September 30, 2020 | 0.3472 |
| June 30, 2020 | 0.3345 |
| March 31, 2020 | 0.3728 |
| December 31, 2019 | 0.2743 |
| September 30, 2019 | 0.3195 |
| June 30, 2019 | 0.3031 |
| March 31, 2019 | 0.3318 |
| December 31, 2018 | 0.2698 |
| September 30, 2018 | 0.2916 |
| June 30, 2018 | 0.3413 |
| March 31, 2018 | 0.3629 |
| December 31, 2017 | 0.2658 |
| Date | Value |
|---|---|
| September 30, 2017 | 0.3129 |
| June 30, 2017 | 0.2965 |
| March 31, 2017 | 0.2908 |
| December 31, 2016 | 0.2509 |
| September 30, 2016 | 0.2901 |
| June 30, 2016 | 0.2976 |
| March 31, 2016 | 0.2743 |
| December 31, 2015 | 0.2376 |
| September 30, 2015 | 0.2427 |
| June 30, 2015 | 0.2391 |
| March 31, 2015 | 0.287 |
| December 31, 2014 | 0.2106 |
| September 30, 2014 | 0.2196 |
| June 30, 2014 | 0.2444 |
| March 31, 2014 | 0.223 |
| December 31, 2013 | 0.2071 |
| September 30, 2013 | 0.2124 |
| June 30, 2013 | 0.2181 |
| March 31, 2013 | 0.1947 |
| December 31, 2012 | 0.1831 |
| September 30, 2012 | 0.1734 |
| June 30, 2012 | 0.167 |
| March 31, 2012 | 0.7335 |
| December 31, 2011 | 0.1508 |
| September 30, 2011 | 0.1402 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
0.2743
Minimum
Dec 2019
0.7302
Maximum
Sep 2023
0.4399
Average
0.4178
Median
Sep 2021
EPS Diluted (Quarterly) Benchmarks
| Amgen Inc | 1.42 |
| AstraZeneca PLC | 0.70 |
| Vertex Pharmaceuticals Inc | 3.71 |
| Viking Therapeutics Inc | -0.26 |
| Evaxion Biotech AS | -1.50 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 3.170B |
| Revenue (Quarterly) | 9.505B |
| Total Expenses (Quarterly) | 5.643B |
| Enterprise Value | 575.12B |
| Gross Profit Margin (Quarterly) | 84.80% |
| Profit Margin (Quarterly) | 33.35% |
| Earnings Yield | 2.09% |
| Operating Earnings Yield | 2.56% |
| Normalized Earnings Yield | 2.092 |